Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis

BACKGROUND: Although American Society of Clinical Oncology and European Society for Medical Oncology guidelines have identified the negative prognostic factors that clinicians have to consider when treating their patients with stage II colon cancer (CC), the role of histological subtype is controver...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Rosati, Gerardo, Galli, Fabio, Cantore, Maurizio, Bergamo, Francesca, Banzi, Maria, Zampino, Maria Giulia, Mattioli, Rodolfo, Cardellino, Giovanni Gerardo, Ronzoni, Monica, Di Bartolomeo, Maria, Tamberi, Stefano, Marchetti, Paolo, Rimassa, Lorenza, Corsi, Domenico, Bochicchio, Anna Maria, Artioli, Fabrizio, Labianca, Roberto, Galli, Francesca, Rulli, Eliana, Bilancia, Domenico, Bregni, Giacomo
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Gastrointestinal Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288638/
https://ncbi.nlm.nih.gov/pubmed/31943506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0736
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares